Biostor Ireland

Executive Summary

Biostór Ireland is a Dublin-based EU-licensed company specializing in the storage, management, and global distribution of biological materials, with a focus on supporting clinical trials. Founded in 2015, the company operates in the cell therapy and biologics sectors, offering comprehensive sample management services that adhere to stringent quality and compliance standards. Biostór's expertise in cold chain logistics and regulatory adherence positions it as a reliable partner for pharmaceutical and biotech firms conducting complex clinical studies. As clinical trials increasingly rely on advanced therapies and decentralized models, demand for specialized storage and distribution services is growing, benefiting Biostór's niche capabilities. The company's private status and limited public information suggest a steady, service-oriented growth trajectory rather than high-risk innovation. However, its EU license and focus on compliance provide a competitive edge in a fragmented market. Overall, Biostór represents a stable, infrastructure-critical player in the cell therapy and biologics ecosystem, with potential for steady revenue growth as it expands its client base and service offerings.

Upcoming Catalysts (preview)

• Q4 2026Major pharma contract for clinical trial sample management65% success
• Q1 2027Expansion of cold chain logistics for cell and gene therapies70% success
• Q3 2026ISO 20387 certification or new facility regulatory approval80% success